TITLE

Canada needs viral hepatitis action plan

AUTHOR(S)
Peltekian, Kevork M.; Hirsch, Geri; Burgess, Carla
PUB. DATE
October 2011
SOURCE
CMAJ: Canadian Medical Association Journal;10/18/2011, Vol. 183 Issue 15, p1751
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor is presented in response to the article "The Cedar Project: risk factors for transition to injection drug use among young, urban Aboriginal people," by C. L. Miller and colleagues in a 2011 issue, which discusses the need to prevent hepatitis C virus infection in Canada.
ACCESSION #
67099489

 

Related Articles

  • Preventing Vertical Hepatitis C Virus Transmission. Schackman, Bruce R.; Oneda, Kawai // Clinical Infectious Diseases;9/15/2007, Vol. 45 Issue 6, p802 

    A letter to the editor is presented in response to the article "Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis," by CB Polis and colleagues in a previous issue.

  • High-Quality Meta-Analyses Are Required for Development of Evidence in Medicine. Aalaei-Andabili, Seyed Hossein; Alavian, Seyed Moayed // Journal of Infectious Diseases;5/1/2012, Vol. 205 Issue 9, p1472 

    A letter to the editor is presented in response to the article "A systematic review and meta analysis of interventions to prevent hepatitis C virus infection in people who inject drugs," by H. Hagan, E. R. Pouget and D.C. Des Jarlais in a 2011 issue of the journal.

  • Reply to ''High-Quality Meta-Analyses Are Required for Development of Evidence in Medicine''. Hagan, Holly; Jarlais, Don C. Des; Pouget, Enrique // Journal of Infectious Diseases;5/1/2012, Vol. 205 Issue 9, p1473 

    A response by Holly Hagan, Don C. Des Jarlais and Enrique Pouget to a letter to the editor about his article "A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs,\" in a 2011 issue of the journal, which discusses the treatment...

  • Erratum: Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program. Garcia-Tsao, Guadalupe; Lim, Joseph // American Journal of Gastroenterology;Jul2009, Vol. 104 Issue 7, p1894 

    A correction to the article "Management and Treatment of Patients With Cirrhosis and Portal Hypertension: Recommendations From the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program," published in the May 19, 2009 issue, is presented.

  • Hepatitis C Vaccine? Breindl, Anette // BioWorld Today;2/28/2011, Vol. 22 Issue 39, Special section p2 

    The article reports on a vaccine developed by researchers at the University of Copenhagen which can protect mice from developing hepatitis C.

  • The silent plague. McPhee, A.T. // Current Science;9/25/98, Vol. 84 Issue 2, p4 

    Offers information on hepatitis C, a virus which destroys the liver. Approval of a treatment by the United States Food and Drug Administration to prevent the damages caused by the disease; Estimated amount of persons in the world infected with the disease; Effect of the disease on the liver. ...

  • Berenguer J et al (Clin Infect Dis 2011; 52:728–36).  // Clinical Infectious Diseases;Dec2012, Vol. 55 Issue 12, p1748 

    A correction to the article "Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and hepatitis C virus," is presented.

  • Hepatitis C advances in vaccine, medicines and website.  // Gastrointestinal Nursing;Feb2013, Vol. 11 Issue 1, p6 

    The article discusses Hepatitis C (HCV) and its vaccines. Since HCV is asymptotic, pharmaceutical company Boehringer Ingelheim has launched a website HepCRedefined.com to help patients. A team at Oxford has calculated a model to determine the spread of HCV while another team is working on...

  • Eliminating hepatitis C as a public health issue. Cox, Jane // Gastrointestinal Nursing;2015 Supplement, Vol. 13 Issue Sup9, pS9 

    The article examines how health professionals in Great Britain can promote new drugs and treatments for eliminating the hepatitis C virus (HCV). Topics discussed include the standardization of current HCV treatments by the National Institute for Health and Care and improved cure rates resulting...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics